Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Leyla Soleymani, Ali Zarrabi, Farid Hashemi, et al.
Current Cancer Drug Targets (2021) Vol. 21, Iss. 9, pp. 749-767
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 141
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 121
Targeting PI3K/Akt signaling in prostate cancer therapy
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 43
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114168-114168
Open Access | Times Cited: 24
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 40
Unlocking melanoma Suppression: Insights from Plasma-Induced potent miRNAs through PI3K-AKT-ZEB1 axis
Pradeep Bhartiya, Apurva Jaiswal, Manorma Negi, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 6
Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: distinct and concerted control
Xianzhe Huang, Wenwei Chen, Yanyan Wang, et al.
Frontiers of Medicine (2025)
Closed Access
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 33
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation
Mojdeh Amini Faskhoudi, Pejman Molaei, Mehrdokht Sadrkhanloo, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153851-153851
Closed Access | Times Cited: 26
The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer
Ealia Khosh Kish, Muhammad Choudhry, Yaser Gamallat, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4772-4772
Open Access | Times Cited: 26
PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming
Yinghui Hao, Fangmei Xie, Jieyi He, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 169, pp. 106554-106554
Closed Access | Times Cited: 3
Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs
Muhammad Sarfraz, Abida Khan, Lina Eltaib, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155179-155179
Closed Access | Times Cited: 2
Epithelial-to-mesenchymal transition and NF-kB pathways are promoted by a mutant form of DDB2, unable to bind PCNA, in UV-damaged human cells
Paola Perucca, Elisabetta Bassi, Martina Vetro, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial–Mesenchymal Transition
Kai‐Ting Chuang, Shyh‐Shin Chiou, Shih‐Hsien Hsu
Cancers (2023) Vol. 15, Iss. 13, pp. 3338-3338
Open Access | Times Cited: 7
PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma
Guoli Feng, Changju Chen, Yi Luo
Oncology Reports (2023) Vol. 50, Iss. 6
Open Access | Times Cited: 6
ZEB1 promotes DNA homologous recombination repair and contributes to the 5-Fluorouracil resistance in colorectal cancer.
Chao Wu, Wenjing Shi, Sen Zhang
PubMed (2023) Vol. 13, Iss. 9, pp. 4101-4114
Closed Access | Times Cited: 5
Expression Profiling of EMT Transcriptional Regulators ZEB1 and ZEB2 in Different Histopathological Grades of Oral Squamous Cell Carcinoma Patients
Neha Baqai, Rafat Amin, Tehseen Fatima, et al.
Current Genomics (2024) Vol. 25, Iss. 2, pp. 140-151
Open Access | Times Cited: 1
Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications
Bingnan Lu, Yifan Liu, Yuntao Yao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets
Xiangpeng Wang, Xiaoxia Xue, Mingshi Pang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 1
The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility
Yuanshuai Su, Chengzhi Li, Yu Fang, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 2, pp. 293-305
Open Access | Times Cited: 8
Transcriptional dynamics of delaminating neuroblasts in the mouse otic vesicle
Maggie S. Matern, Robert Durruthy-Durruthy, Onur Birol, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112545-112545
Open Access | Times Cited: 3
Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
Jianjun Li, Yaqi Kou, Xiaohan Zhang, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Role of E-cadherin and β-catenin in head and neck squamous cell carcinoma
A. A. Petrova, S. I. Samoylova, L. V. Magomedkerimova, et al.
Siberian Journal of Oncology (2024) Vol. 22, Iss. 6, pp. 130-137
Open Access
Deciphering the prognostic significance and regulatory networks of ZEB1 and ZEB2 in prostate adenocarcinoma
Feyzanur Çaldıran
Experimental Biomedical Research (2024)
Open Access
Cordycepin Enhanced Therapeutic Potential of Gemcitabine against Cholangiocarcinoma via Downregulating Cancer Stem-Like Properties
Hong Kyu Lee, Yun-Jung Na, Su‐Min Seong, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 368-378
Open Access
Page 1 - Next Page

Scroll to top